Humacyte (HUMA) Inventory (2025 - 2026)
Humacyte (HUMA) posted quarterly Inventory of $9.9 million for Q1 2026, up 23.69% year-over-year from $8.0 million in Q1 2025, and down 55.88% quarter-over-quarter from $22.5 million in Q4 2025.
Humacyte (HUMA) Inventory (2025 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Inventory for 2 consecutive years, with $9.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 23.69% year-over-year to $9.9 million; the TTM figure through Mar 2026 stood at $9.9 million (up 23.69% YoY), while the FY2025 annual figure was $22.5 million, changed N/A from the prior year.
- Inventory eased to $9.9 million in Q1 2026 per HUMA's latest filing, from $22.5 million in the prior quarter.
- Across five years, Inventory topped out at $22.5 million in Q4 2025 and bottomed at $8.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Humacyte | 150.77 Mn | 150.77 Mn | -825,000.00 | 18.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.20 Mn |
| Mar 31, 2026 | 9.92 Mn |
| Dec 31, 2025 | 22.49 Mn |
| Sep 30, 2025 | 18.42 Mn |
| Jun 30, 2025 | 11.07 Mn |
| Mar 31, 2025 | 8.02 Mn |